Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 144

1.

Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.

Yu XM, Phan T, Patel PN, Jaskula-Sztul R, Chen H.

Cancer. 2013 Feb 15;119(4):774-81. doi: 10.1002/cncr.27742. Epub 2012 Sep 18.

PMID:
22991264
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.

Ning L, Jaskula-Sztul R, Kunnimalaiyaan M, Chen H.

Ann Surg Oncol. 2008 Sep;15(9):2600-5. doi: 10.1245/s10434-008-0006-z. Epub 2008 Jun 18.

PMID:
18563491
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth.

Yu XM, Jaskula-Sztul R, Ahmed K, Harrison AD, Kunnimalaiyaan M, Chen H.

Mol Cancer Ther. 2013 Jul;12(7):1276-87. doi: 10.1158/1535-7163.MCT-12-0841. Epub 2013 Apr 17.

PMID:
23594881
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Antiproliferative effect of chrysin on anaplastic thyroid cancer.

Phan T, Yu XM, Kunnimalaiyaan M, Chen H.

J Surg Res. 2011 Sep;170(1):84-8. doi: 10.1016/j.jss.2011.03.064. Epub 2011 Apr 20.

PMID:
21571321
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Inhibition of gamma-secretase activity impedes uterine serous carcinoma growth in a human xenograft model.

Groeneweg JW, Hall TR, Zhang L, Kim M, Byron VF, Tambouret R, Sathayanrayanan S, Foster R, Rueda BR, Growdon WB.

Gynecol Oncol. 2014 Jun;133(3):607-15. doi: 10.1016/j.ygyno.2014.03.560. Epub 2014 Mar 22.

PMID:
24667249
[PubMed - indexed for MEDLINE]
6.

Hesperetin Activates the Notch1 Signaling Cascade, Causes Apoptosis, and Induces Cellular Differentiation in Anaplastic Thyroid Cancer.

Patel PN, Yu XM, Jaskula-Sztul R, Chen H.

Ann Surg Oncol. 2014 Jan 14. [Epub ahead of print]

PMID:
24419754
[PubMed - as supplied by publisher]
7.

Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.

Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN.

Clin Cancer Res. 2006 Aug 1;12(15):4755-65.

PMID:
16899627
[PubMed - indexed for MEDLINE]
Free Article
8.

Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.

Ning L, Greenblatt DY, Kunnimalaiyaan M, Chen H.

Oncologist. 2008 Feb;13(2):98-104. doi: 10.1634/theoncologist.2007-0190.

PMID:
18305053
[PubMed - indexed for MEDLINE]
Free Article
9.

Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.

Greenblatt DY, Cayo MA, Adler JT, Ning L, Haymart MR, Kunnimalaiyaan M, Chen H.

Ann Surg. 2008 Jun;247(6):1036-40. doi: 10.1097/SLA.0b013e3181758d0e.

PMID:
18520232
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Epidermal growth factor receptor (EGFR) is overexpressed in anaplastic thyroid cancer, and the EGFR inhibitor gefitinib inhibits the growth of anaplastic thyroid cancer.

Schiff BA, McMurphy AB, Jasser SA, Younes MN, Doan D, Yigitbasi OG, Kim S, Zhou G, Mandal M, Bekele BN, Holsinger FC, Sherman SI, Yeung SC, El-Naggar AK, Myers JN.

Clin Cancer Res. 2004 Dec 15;10(24):8594-602.

PMID:
15623643
[PubMed - indexed for MEDLINE]
Free Article
11.

Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells.

Greenblatt DY, Vaccaro AM, Jaskula-Sztul R, Ning L, Haymart M, Kunnimalaiyaan M, Chen H.

Oncologist. 2007 Aug;12(8):942-51.

PMID:
17766653
[PubMed - indexed for MEDLINE]
Free Article
12.

Expression of the active Notch1 decreases MTC tumor growth in vivo.

Jaskula-Sztul R, Pisarnturakit P, Landowski M, Chen H, Kunnimalaiyaan M.

J Surg Res. 2011 Nov;171(1):23-7. doi: 10.1016/j.jss.2011.03.035. Epub 2011 Apr 13.

PMID:
21571316
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.

Straight AM, Oakley K, Moores R, Bauer AJ, Patel A, Tuttle RM, Jimeno J, Francis GL.

Cancer Chemother Pharmacol. 2006 Jan;57(1):7-14. Epub 2005 Nov 5.

PMID:
16001179
[PubMed - indexed for MEDLINE]
14.

Valproic acid induces Notch1 signaling in small cell lung cancer cells.

Platta CS, Greenblatt DY, Kunnimalaiyaan M, Chen H.

J Surg Res. 2008 Jul;148(1):31-7. doi: 10.1016/j.jss.2008.03.008. Epub 2008 Apr 10.

PMID:
18570928
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.

Kunnimalaiyaan M, Vaccaro AM, Ndiaye MA, Chen H.

J Biol Chem. 2006 Dec 29;281(52):39819-30. Epub 2006 Nov 7.

PMID:
17090547
[PubMed - indexed for MEDLINE]
Free Article
16.

Antitumor effects of proteasome inhibition in anaplastic thyroid carcinoma.

Altmann A, Markert A, Askoxylakis V, Schöning T, Jesenofsky R, Eisenhut M, Haberkorn U.

J Nucl Med. 2012 Nov;53(11):1764-71. doi: 10.2967/jnumed.111.101295. Epub 2012 Oct 10.

PMID:
23055533
[PubMed - indexed for MEDLINE]
Free Article
17.

Epigenetic regulation of Delta-Like1 controls Notch1 activation in gastric cancer.

Piazzi G, Fini L, Selgrad M, Garcia M, Daoud Y, Wex T, Malfertheiner P, Gasbarrini A, Romano M, Meyer RL, Genta RM, Fox JG, Boland CR, Bazzoli F, Ricciardiello L.

Oncotarget. 2011 Dec;2(12):1291-301.

PMID:
22249198
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

NOTCH1 signaling as a therapeutic target in Sézary syndrome.

van der Fits L, Qin Y, Out-Luiting JJ, Vermeer KG, Whittaker S, van Es JH, Tensen CP, Vermeer MH.

J Invest Dermatol. 2012 Dec;132(12):2810-7. doi: 10.1038/jid.2012.203. Epub 2012 Jun 21.

PMID:
22718117
[PubMed - indexed for MEDLINE]
Free Article
19.

Notch activation inhibits AML growth and survival: a potential therapeutic approach.

Kannan S, Sutphin RM, Hall MG, Golfman LS, Fang W, Nolo RM, Akers LJ, Hammitt RA, McMurray JS, Kornblau SM, Melnick AM, Figueroa ME, Zweidler-McKay PA.

J Exp Med. 2013 Feb 11;210(2):321-37. doi: 10.1084/jem.20121527. Epub 2013 Jan 28.

PMID:
23359069
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The tyrosine kinase inhibitor, AZD2171, inhibits vascular endothelial growth factor receptor signaling and growth of anaplastic thyroid cancer in an orthotopic nude mouse model.

Gomez-Rivera F, Santillan-Gomez AA, Younes MN, Kim S, Fooshee D, Zhao M, Jasser SA, Myers JN.

Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4519-27.

PMID:
17671138
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk